Asymmetric stock research

One weird monster is better than twenty maybe-stocks.

A living dashboard of Wolfgang’s long-term 5–10x watchlist: selective public companies with hidden infrastructure, platform optionality, and explicit kill rules.

3active recommendations

5–10yintended research horizon

0–3weekly pass threshold, never padded

Not a trade feed.

This page tracks deep-research watchlist ideas only. No automatic buying. Every name needs a plausible 5–10x path and clear disconfirmation rules.

Current recommendations

Generated from asymmetric_stock_watchlist.json. Last rebuilt 2026-05-31 09:47 UTC.

Active Watchlist

PAYO

Payoneer Global Inc.

84score

Global SMB cross-border commerce infrastructure mispriced as a commodity/rate-sensitive fintech. Payoneer combines regulated local rails, marketplace relationships, multi-currency accounts, AP/AR, working capital, and payout workflows across 7,000+ corridors and nearly 2M active customers. If core volume reaccelerates and margins scale, it has a plausible 5-10 year path to multi-billion revenue and $15B+ equity value.

Approx. $1.8B equity value using Yahoo chart price around $4.96 and ~360M share count estimate; Q1 2026 revenue $261.6M, operating income $30.0M, net income $19.6M.

switching costsscale economiesbrandpartial network effectscornered resource regulatory local railsprocess power risk compliance localization

Kill / sell rules

Remove if two consecutive quarters show deteriorating active customers plus sub-10% core revenue growth.
Remove if compliance/fraud losses materially impair trust.
Remove if management uses cash for dilutive or unfocused M&A.
Remove if gross/transaction economics structurally compress.
Remove if thesis depends mainly on interest income rather than durable payments volume.

Source 1 Source 2 Source 3 Source 4 Source 5

Active Watchlist

BWMN

Bowman Consulting Group Ltd.

82score

Founder-led national infrastructure engineering/services consolidator in a fragmented AEC market. The market may price Bowman as a cyclical consultant, while the upside case is a Strata-like hidden workflow platform: local mission-critical relationships plus national scale, geospatial/automation tooling, public infrastructure tailwinds, and a bolt-on acquisition flywheel.

Approx. $0.55B equity value using Yahoo chart price around $33.32 and Q1 2026 weighted average shares of ~16.45M; Q1 2026 gross contract revenue $126.5M, net loss $3.7M, adjusted EBITDA $16.8M.

scale economiesswitching costs client project historyprocess power acquisition integration geospatial QAbrand emerginglimited network effects cross office referralscounter positioning mid sized local national model

Kill / sell rules

Remove if leverage rises above a conservative service-business range without credible deleveraging path.
Remove if two or more quarters show revenue growth driven mostly by acquisitions while margins/backlog deteriorate.
Remove if cash conversion remains poor for a full year.
Remove if Gary Bowman materially reduces involvement without proven succession.
Remove if acquisitions become larger and strategically unfocused.

Source 1 Source 2 Source 3 Source 4 Source 5

Watchlist High Risk Convex

SDGR

Schrödinger, Inc.

7.4score

Computational chemistry / molecular-design software platform with drug-discovery optionality; could become mission-critical R&D infrastructure if AI-enabled molecular simulation adoption broadens.

5–10x plausible but high risk if software/platform revenue scales to $500–700M+, margins become software-like, and pipeline/milestone economics add upside from a sub-$1B market cap.

987807936

Kill / sell rules

software revenue stalls for multiple quarters
annual cash burn accelerates without commercial traction
cash runway below roughly two years
management shifts too far toward self-funded biotech risk
gross margin/platform retention deteriorates

Key risks

weak or lumpy revenue growth
high operating burn
internal pipeline consuming too much capital
AI drug-discovery hype compression
software retention/gross margin deterioration

Source 1 Source 2 Source 3 Source 4 Source 5

Financial trajectory

Revenue and net income snapshots for context. Data source is yfinance; some histories can be incomplete around ticker changes or restructurings.

Revenue and net income chart — Revenue + Net Income — 5 fiscal years

Selection method

Quality over quantity. The research job should return zero when nothing clears the bar.

10x pathLarge TAM, operating leverage, and a credible route to much higher equity value.

MisunderstandingMarket sees a boring niche; thesis sees mission-critical infrastructure or platform optionality.

Seven PowersScale economies, switching costs, process power, brand, network effects, or cornered resources.

Kill rulesEach idea includes explicit evidence that would invalidate the thesis.